Literature DB >> 904526

Three instructive cases of tiger snake (Notechis scutatus) envenomation--and how a radioimmunoassay proved the diagnosis.

S K Sutherland, A R Coulter.   

Abstract

Three unusual cases are described, in which, in separate incidents, young snake bite victims were found comatose. Tiger snake vemon was detected by radioimmunoassay in the urine and serum, and in one case on the clothing of these children. Gross myoglobinuria was present in all cases. The three cases demonstrate clearly the myolytic potential of tiger snake venom if specific treatment (administration of antivenom) is delayed. Extreme elevation of serum enzyme levels was found in the two victims who survived. Evidence was obtained that the major neurotoxin of tiger snake venom is absorbed at least partly via the lymphatics and that some is excreted in the urine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 904526

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  4 in total

1.  The effects of the subcutaneous injection of the crude venom of the Australian common brown snake, Pseudonaja textilis on the skeletal neuromuscular system.

Authors:  J B Harris; C A Maltin
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

2.  Myotoxic phospholipases A from snake venom, Pseudechis colletti, producing myoglobinuria in mice.

Authors:  D Mebs; Y Samejima
Journal:  Experientia       Date:  1980-07-15

3.  Myotoxic activity of the crude venom and the principal neurotoxin, taipoxin, of the Australian taipan, Oxyuranus scutellatus.

Authors:  J B Harris; C A Maltin
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

Review 4.  Secreted phospholipases A2 of snake venoms: effects on the peripheral neuromuscular system with comments on the role of phospholipases A2 in disorders of the CNS and their uses in industry.

Authors:  John B Harris; Tracey Scott-Davey
Journal:  Toxins (Basel)       Date:  2013-12-17       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.